Cite
HARVARD Citation
Zhao, N. et al. (2023). LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry. Digestive and liver disease. 55 (5), pp. 661-672. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhao, N. et al. (2023). LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry. Digestive and liver disease. 55 (5), pp. 661-672. [Online].